Vol. 29 No. 3 (2025): SEPTEMBER - DECEMBER

Original articles

VM Huaman Macha, DJ Orccosupa Quispe, A Wong Chang, D Del Carpio Jayo

8-14

Clinical and hematological profile and frequency of thromboembolic events in patients with essential thrombocythemia treated at a Peruvian referral hospital.

https://doi.org/10.48057/hematologa.v29i3.679

pdf (Español (España)) html (Español (España))

Anatomo-clinic discussion of the hematology fellowships

A Quesada, MJ Mallorquin, GE Castelli, S Lopresti, D Villalba

35-39

Chronic inflammatory demyelinating polyneuropathy: the least expected culprit

https://doi.org/10.48057/hematologa.v29i3.633

pdf (Español (España)) html (Español (España))

Updates and/or revisions

SX, LA Jaramillo-Aguilar, DI Flores-Carpio, TA Guamán-Caguana, M Feijó-Erazo, MG Jaramillo-Cabrera

27-34

Hematologic diseases and air pollution: a narrative literature review

https://doi.org/10.48057/hematologa.v29i3.670

pdf (Español (España)) html (Español (España))

J Ceresetto

15-26

Immune Thrombocytopenic Purpura (ITP) as a thrombo-hemorrhagic entity: role of Fostamatinib

https://doi.org/10.48057/hematologa.v29i3.689

html (Español (España)) pdf (Español (España))

Pediatric Hematology

PL Noroña, LE Morán, ML Fernández, M Gutierrez, P Sosa, SN Borda

71-75

Chronic hemolytic anemia associated with a SPTA1 gene variant (1q23.1): a case report.

https://doi.org/10.48057/hematologa.v29i3.676

pdf (Español (España)) html (Español (España))

New Drugs in Hematology

Marta Zerga

61-70

New therapeutic options for relapsed/refractory diffuse large b-cell lymphoma. Treatment with tafasitamab + lenalidomide

https://doi.org/10.48057/hematologa.v29i3.687

pdf (Español (España)) html (Español (España))

Laboratory

MP González Cid, C Benavídez, RV García, DE Mendoza, MC Sala, CJ Goedelmann

76-82

Total iron-binding capacity determination

https://doi.org/10.48057/hematologa.v29i3.672

pdf (Español (España)) html (Español (España))

Clinical case

AC Chiliquinga Carvajal, V Arias Adriano, G Musello Farina, F Jiménez Jaramillo, C Gordón Gordón

44-48

Hemophagocytic syndrome secondary to diffuse large B-cell primary lymphoma of the spleen: first case reported in Ecuador.

https://doi.org/10.48057/hematologa.v29i3.623

pdf (Español (España)) html (Español (España))

M, J Paviolo

55-60

Clinical case: POEMS syndrome

https://doi.org/10.48057/hematologa.v29i3.659

pdf (Español (España)) html (Español (España))

MA Montiel Alfonso, JM, J, L Cardozo

49-54

Atypical bone involvement in chronic lymphocytic leukemia: clinical response to BTK inhibition after chemotherapy failure

https://doi.org/10.48057/hematologa.v29i3.648

pdf (Español (España)) html (Español (España))

H Chiang, MC González-Guzmán, T Alarcón-Guzmán, M Patiño-Patiño, LR Layedra-Bardi

40-43

Intrasellar plasmacytoma simulating a non-functioning pituitary adenoma in relapsed multiple myeloma.

https://doi.org/10.48057/hematologa.v29i3.650

pdf (Español (España)) html (Español (España))

Imaging in Hematology

D Colimodio, P Melchiori, E Carricondo

83-86

Perls' Stain: the cytochemical test surviving in modern hematology. Key to luspatercept eligibility in MDS-associated anemia

https://doi.org/10.48057/hematologa.v29i3.680

pdf (Español (España)) html (Español (España))